Cargando…

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?

Detalles Bibliográficos
Autores principales:	Macaluso, Fabio Salvatore, Orlando, Ambrogio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214317/ https://www.ncbi.nlm.nih.gov/pubmed/32407807 http://dx.doi.org/10.1053/j.gastro.2020.05.026

Ejemplares similares

Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2020)

Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
por: Louis, Edouard
Publicado: (2020)

Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Cholinergic immunomodulation in inflammatory bowel diseases
por: Serafini, Michele A., et al.
Publicado: (2021)

The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
por: Watson, James A., et al.
Publicado: (2023)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
por: Krusiński, Adam, et al.
Publicado: (2021)

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
por: Selim, Rania, et al.
Publicado: (2021)

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
por: Barberio, Brigida, et al.
Publicado: (2021)

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy
por: Selim, Rania, et al.
Publicado: (2022)

Immunomodulators in COVID-19: Two Sides to Every Coin
por: Snow, Timothy A. C., et al.
Publicado: (2020)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022)

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
por: Al‐Janabi, A., et al.
Publicado: (2021)

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
por: Barberio, Brigida, et al.
Publicado: (2021)

The future of robotic surgery for inflammatory bowel diseases
por: Gul, Fahad, et al.
Publicado: (2022)

Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology–Surgery Team to Include an Infectious Disease Specialist
por: Bezzio, Cristina, et al.
Publicado: (2021)

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Inflammatory bowel disease in Lebanon: a plea for help
por: Mourad, Fadi H, et al.
Publicado: (2022)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
por: Lichtenstein, Gary R, et al.
Publicado: (2012)

Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic
por: Kotze, Paulo Gustavo, et al.
Publicado: (2021)

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
por: Prentice, Ralley E., et al.
Publicado: (2020)

Adalimumab for treatment of very early onset inflammatory bowel disease
por: Xie, Yao, et al.
Publicado: (2019)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
por: Reinholz, Markus, et al.
Publicado: (2021)

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
por: Zingone, Fabiana, et al.
Publicado: (2020)

Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
por: Teich, Niels, et al.
Publicado: (2022)

Systematic review with meta‐analysis: the effects of immunomodulator or biological withdrawal from mono‐ or combination therapy in inflammatory bowel disease
por: Dohos, Dóra, et al.
Publicado: (2020)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
por: Nardone, Olga Maria, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
por: Brain, Oliver, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6np6qdffkj7read2ehovqqrglc